OXGN - OxiGene Inc.

$1.08 -0.03 | -2.70%
Today's Range: 1.06 - 1.14
OXGN Avg. Daily Volume: 324,542
12/18/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 1.08
52 Week High 2.78
52 Week Low 0.52
Avg. Daily Vol. (Mil) 0.33
Beta (3 year) 1.80
Share Related Items
Mkt Cap (Mil) 67.46
Shares Out (Mil) 62.46
Float (Mil) 60.48
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.80
Current Ratio 2.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 5.20
Price/Cash Flow -2.40
Per Share Data
Earnings -0.52
Sales 0.00
Book Value 0.21
Cash Flow -0.46
Business Summary
A clinical-stage biopharmaceutical company, which develops novel therapeutics to treat cancer and eye diseases.
General Information
230 Third Avenue
Waltham, MA 02451
www.oxigene.com
Industry : Drugs
Sector: Health Care
Employees: 34
CEO: Dr. Peter J. Langecker,
Short Interest
Current Month (Mil) 2.93
Previous Month (Mil) 2.19
Short Interest Ratio (Days) 9.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -118.30
Return on Investments -221.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Latest OXGN Headlines

Brokerage Partners

TheStreet Premium Services

All Services